REVATIS
RevaTis provides treatments in regenerative medicine such as the production and the preventive biobanking of autologous stem cells. it promotes the use by partners of its aseptic isolators packaged in a complete ‘turnkey’ system that includes quality management system and electronic batch record, making it fully GMP compliant. RevaTis, a spin-off from Liege University, in Belgium, was founded end 2013 and focuses on advanced regenerative medicine and cell therapy. Its growth is underpinned by its innovative and patented technology to obtain pluripotent adult Mesenchymal Stem Cells from a minimally invasive muscle micro-biopsy.
REVATIS
Industry:
Biotechnology Health Care Medical
Founded:
2013-01-01
Address:
College Station, Texas, United States
Country:
United States
Website Url:
http://www.revatis.com
Total Employee:
1+
Status:
Active
Contact:
32 84 84 02 30
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Global Site Tag US Privacy User Signal Mechanism Cloudflare Cloudflare Network Error Logging Cloudflare SSL
Similar Organizations
3D-Matrix Medical Inc.
3DMatrix Medical is a regenerative medicine company with products that accelerate wound healing & tissue regeneration.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Precise Bio
Precise Bio is a regenerative medicine company that develops and commercializes 4D bio-fabricated functional tissues and organs.
Current Employees Featured
Official Site Inspections
http://www.revatis.com
- Host name: 104.21.16.1
- IP address: 104.21.16.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "RevaTis"
Revatis S.A.
Revatis is based on the scientific discoveries of Prof. D. Serteyn and Dr J. Ceusters and has solid intellectual property and exceptional know-how. Revatis has a patented technology for obtaining multipotent stem cells from a muscle …See details»
RevaTis - Crunchbase Company Profile & Funding
RevaTis, a spin-off from Liege University, in Belgium, was founded end 2013 and focuses on advanced regenerative medicine and cell therapy. Its growth is underpinned by its innovative …See details»
Revatis S.A.
Revatis est une Spin Off de l'Université de Liège, dédiée à la médecine régénérative et à la thérapie cellulaire. Revatis se base sur les découvertes scientifiques du Prof. D. Serteyn et du Dr. J. Ceusters et dispose d'une …See details»
Revatis Company Profile 2024: Valuation, Funding & Investors
Developer of medical technology designed for advanced regenerative medicine and cell therapy.See details»
Revatis - LinkedIn
Advancing Biomedical Solutions Revatis is dedicated to driving progress in biomedical technology, offering practical solutions that address real-world challenges. With a focus on research and...See details»
Mission, values & team • Revatis S.A.
Revatis produces stem cells in a GMP certified aseptic isolator for batch production of cells for R&D and clinical applications. R&D programs, preclinical and clinical studies bring a new …See details»
RevaTis - Org Chart, Teams, Culture & Jobs - The Org
View RevaTis' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
RevaTis - Products, Competitors, Financials, Employees, …
RevaTis primarily serves the veterinary sector with therapeutic stem cell products for horses and pets, and supplies customized stem cells for banking, research, organ-on-chip models, and 3D …See details»
Revatis Company Profile | Marche-en-Famenne, Belgium
Find company research, competitor information, contact details & financial data for Revatis of Marche-en-Famenne. Get the latest business insights from Dun & Bradstreet.See details»
Didier Serteyn - CEO at RevaTis - The Org
Didier Serteyn is the CEO at Revatis. Didier graduated doctor of veterinary medicine from the University of Liège in 1982 and obtained his PhD degree in 1989.See details»
Human health • Revatis S.A.
By using its innovative, minimally invasive and patented technology for obtaining multipotent stem cells, Revatis is able to provide its partners with an affordable and reliable supply of stem cells …See details»
RevaTis - VentureRadar
Website: https://revatis.com/ Revatis has a patented technology for obtaining pluripotent stem cells from a muscle micro-biopsy. This technology is available for clinical applications in …See details»
Revatis - Equine Care Group
Revatis aims to produce autologous stem cells for therapeutic use in horses and companion animals. In human medicine, Revatis is positioning itself as a supplier of personalized stem …See details»
RevatisAM • A Revatis subsidiary company
RevatisAM was founded in 2016 in collaboration with Texas A&M University and its growth is underpinned by its innovative and patented technology to obtain pluripotent adult …See details»
Orgenesis Announces Joint Venture Agreement with RevaTis to
Apr 8, 2020 · RevaTis, a spin-off from Liege University in Belgium, was founded in 2013 and is dedicated to advanced regenerative medicine and cell therapy. RevaTis has developed an …See details»
RevaTis' Leadership Team Team - Team members and org chart
The current leadership team at RevaTis has a wealth of experience in the industry. The team has worked together for many years and has a proven track record of success. They have a deep …See details»
Research & Development • Revatis S.A.
Revatis' own research is carried out mainly in collaboration with the Center for Oxygen, Research and Development (CORD) of the University of Liège. They focus on differentiation capacities, …See details»
Partnerships • Revatis S.A.
Within the general framework of reducing animal experimentation, Revatis offers undifferentiated or differentiated cells to partners involved in the production of organs on a chip or organoids. …See details»
Orgenesis signs muscle-derived stem cell pact - Bioprocess Insider
Apr 13, 2020 · Orgenesis has added muscle-derived stem cells to its offering through a manufacturing joint venture with Revatis. The partnership will supply developers of autologous …See details»
Revatis S.A. • Participation of Revatis in the BIO congress
Revatis is taking part in the 2021 edition of BIO Digital (www.bio.org), to promote its stem cell expertise and the promising benefits of muscle-derived mesenchymal stem cells.See details»